1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Guizhou Xinbang Pharmaceutical Co., Ltd.
  6. Summary
    002390   CNE100000NG5

GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.

(002390)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-06-30
7.220 CNY   +4.49%
05/18Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Implementation of Final Cash Dividend for 2021, Payable on 24 May 2022
CI
05/09Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend
CI
04/29Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
6.65 6.63 6.64 6.91 7.22 Last
48456050 38422610 28314340 42730410 52867720 Volume
+1.22% -0.30% +0.15% +4.07% +4.49% Change
Estimated financial data (e)
Sales 2022 7 180 M 1 071 M 1 071 M
Net income 2022 353 M 52,7 M 52,7 M
Net Debt 2022 - - -
P/E ratio 2022 42,5x
Yield 2022 -
Sales 2023 7 990 M 1 192 M 1 192 M
Net income 2023 429 M 64,0 M 64,0 M
Net Debt 2023 - - -
P/E ratio 2023 34,4x
Yield 2023 -
Capitalization 14 035 M 2 094 M 2 094 M
Capi. / Sales 2022 1,95x
Capi. / Sales 2023 1,76x
Nbr of Employees 5 796
Free-Float 53,0%
More Financials
Company
GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment... 
Sector
Pharmaceuticals
Calendar
08/30Earnings Release
More about the company
Ratings of Guizhou Xinbang Pharmaceutical Co., Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
05/18Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Implementation of Final Cash Dividen..
CI
05/09Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend
CI
04/29Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter..
CI
04/15Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Final Cash Dividend Proposal for 202..
CI
04/14Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year End..
CI
2021Guizhou Kekai Medicine Co., Ltd. announced that it expects to receive CNY 461.450506 mi..
CI
2021Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
2021Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2021Jiangsu Hospital of Traditional Chinese Medicine Medical Development completed the acqu..
CI
2021Guizhou Zhixin Enterprise Management Consulting Partnership Enterprise (Limited Partner..
CI
2021Guizhou Zhixin Enterprise Management Consulting Partnership Enterprise (Limited Partner..
CI
2021Jiangsu Hospital of Traditional Chinese Medicine Medical Development agreed to acquire ..
CI
2021Guizhou Xinbang Pharmaceutical Co., Ltd. announced that it has received CNY 1.512 billi..
CI
2021Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter..
CI
2021Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year End..
CI
More news
News in other languages on GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
05/18Guizhou Xinbang Pharmaceutical Co., Ltd. annonce la mise en place d'un dividende final ..
05/09La société Guizhou Xinbang Pharmaceutical Co., Ltd. approuve le dividende en espèces
04/29Guizhou Xinbang Pharmaceutical Co., Ltd. annonce ses résultats pour le premier trimestr..
04/15Guizhou Xinbang Pharmaceutical Co., Ltd. annonce la proposition finale de dividende en ..
04/14Guizhou Xinbang Pharmaceutical Co., Ltd. annonce ses résultats pour l'année complète se..
More news
Chart GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
Duration : Period :
Guizhou Xinbang Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 7,22 CNY
Average target price 7,37 CNY
Spread / Average Target 2,08%
EPS Revisions
Managers and Directors
Ling Zhong Kong General Manager & Director
Ya Yun Xiao Chief Financial Officer & Deputy General Manager
Huai Lue An Chairman
Peng Wang Chairman-Supervisory Board
Yan An Dong Independent Director